Veradigm (MDRX) Competitors $4.80 -0.05 (-1.03%) As of 03:22 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesSEC FilingsSustainabilityTrendsBuy This Stock MDRX vs. OMCL, HSTM, CRTX, CNGL, OMQS, KBNT, BLIV, DAIC, SAIC, and SCSShould you be buying Veradigm stock or one of its competitors? The main competitors of Veradigm include Omnicell (OMCL), HealthStream (HSTM), Cortexyme (CRTX), Canna-Global Acquisition (CNGL), OMNIQ (OMQS), Kubient (KBNT), Belive (BLIV), CID Holdco (DAIC), Science Applications International (SAIC), and Steelcase (SCS). Veradigm vs. Its Competitors Omnicell HealthStream Cortexyme Canna-Global Acquisition OMNIQ Kubient Belive CID Holdco Science Applications International Steelcase Veradigm (NASDAQ:MDRX) and Omnicell (NASDAQ:OMCL) are both small-cap health care technology companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, earnings, profitability, media sentiment, dividends, analyst recommendations, risk and institutional ownership. Do analysts recommend MDRX or OMCL? Veradigm presently has a consensus price target of $13.00, suggesting a potential upside of 170.83%. Omnicell has a consensus price target of $46.71, suggesting a potential upside of 48.54%. Given Veradigm's higher possible upside, equities analysts plainly believe Veradigm is more favorable than Omnicell.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Veradigm 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Omnicell 1 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.38 Which has more risk & volatility, MDRX or OMCL? Veradigm has a beta of 0.68, suggesting that its stock price is 32% less volatile than the S&P 500. Comparatively, Omnicell has a beta of 0.88, suggesting that its stock price is 12% less volatile than the S&P 500. Which has better valuation and earnings, MDRX or OMCL? Omnicell has lower revenue, but higher earnings than Veradigm. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVeradigm$1.53B0.34N/AN/AN/AOmnicell$1.11B1.30$12.53M$0.5062.90 Is MDRX or OMCL more profitable? Omnicell has a net margin of 2.01% compared to Veradigm's net margin of 0.00%. Omnicell's return on equity of 4.27% beat Veradigm's return on equity.Company Net Margins Return on Equity Return on Assets VeradigmN/A N/A N/A Omnicell 2.01%4.27%2.44% Do institutionals and insiders hold more shares of MDRX or OMCL? 97.7% of Omnicell shares are owned by institutional investors. 2.3% of Veradigm shares are owned by company insiders. Comparatively, 2.5% of Omnicell shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Does the media refer more to MDRX or OMCL? In the previous week, Omnicell had 4 more articles in the media than Veradigm. MarketBeat recorded 7 mentions for Omnicell and 3 mentions for Veradigm. Omnicell's average media sentiment score of 0.67 beat Veradigm's score of 0.37 indicating that Omnicell is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Veradigm 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Omnicell 2 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryOmnicell beats Veradigm on 11 of the 13 factors compared between the two stocks. Get Veradigm News Delivered to You Automatically Sign up to receive the latest news and ratings for MDRX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MDRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MDRX vs. The Competition Export to ExcelMetricVeradigmComputer integrated systems design IndustryBusiness SectorNASDAQ ExchangeMarket Cap$519.67M$1.11B$35.41B$10.65BDividend YieldN/A2.73%2.84%4.74%P/E RatioN/A1.5526.5827.59Price / Sales0.340.24853.50138.47Price / CashN/A9.4430.0561.77Price / BookN/A2.968.366.76Net IncomeN/A$144.65M$195.02M$275.88M7 Day Performance2.13%2.26%3.58%3.72%1 Month Performance-1.03%-2.50%11.85%10.22%1 Year Performance-48.55%-8.67%66.33%35.86% Veradigm Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MDRXVeradigm2.7604 of 5 stars$4.80-1.0%$13.00+170.8%-47.8%$519.67M$1.53B0.008,000News CoverageGap DownOMCLOmnicell3.8549 of 5 stars$30.34-1.2%$46.71+54.0%-28.4%$1.41B$1.11B60.683,670News CoverageAnalyst ForecastHSTMHealthStream4.7306 of 5 stars$28.96-0.6%$31.00+7.0%-5.5%$863.74M$295.21M43.221,093News CoverageAnalyst ForecastCRTXCortexymeN/A$1.61-1.2%N/A+154.2%$48.54MN/A-0.5455CNGLCanna-Global AcquisitionN/A$10.74flatN/AN/A$70.99MN/A0.002OMQSOMNIQN/A$0.10-13.6%N/A-50.0%$1.28M$81.19M-0.04190Gap DownKBNTKubientN/A$0.00flatN/AN/A$1K$1.17M0.0040High Trading VolumeBLIVBeliveN/A$3.72+6.0%N/AN/A$0.00$1.85M0.0034Short Interest ↓Gap DownDAICCID HoldcoN/A$2.84-5.3%N/AN/A$0.00$290.47K0.00N/APositive NewsAnalyst ForecastShort Interest ↓Gap DownSAICScience Applications International4.065 of 5 stars$97.72+0.1%$120.64+23.5%-29.7%$4.50B$7.46B16.4826,000SCSSteelcase3.8744 of 5 stars$17.21+0.7%$16.00-7.0%+30.5%$1.96B$3.26B16.7111,300Positive NewsAnalyst Upgrade Related Companies and Tools Related Companies Omnicell Competitors HealthStream Competitors Cortexyme Competitors Canna-Global Acquisition Competitors OMNIQ Competitors Kubient Competitors Belive Competitors CID Holdco Competitors Science Applications International Competitors Steelcase Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MDRX) was last updated on 10/8/2025 by MarketBeat.com Staff From Our PartnersStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored3 Major A.I. Threats That Could Upend the U.S. EconomyThe media's calling Artificial Intelligence a "revolution," but for many Americans, the real impact might actu...Goldco Precious Metals | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredTrump Devises the Death of the IRS ☠️Trump has just signed an executive order creating America's first-ever National Investment Fund — a game-chang...Angel Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Veradigm Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Veradigm With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
